Whipple's disease differential diagnosis: Difference between revisions
Line 21: | Line 21: | ||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="3" |Cause | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ||
! rowspan="3" |Peak age of onset | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Peak age of onset | ||
! colspan="6" |History | ! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" |History | ||
! rowspan="3" |Physical exam | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Physical exam | ||
! colspan="4" rowspan="2" |Lab findings | ! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Lab findings | ||
! rowspan="3" |Additional finding | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Additional finding | ||
! rowspan="3" |Cause/Pathogenesis | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause/Pathogenesis | ||
! rowspan="3" |Gold standard diagnosis | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard diagnosis | ||
|- | |- | ||
! colspan="2" align="center" style="background:# | ! colspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Diarrhea | ||
! rowspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Fever | |||
! rowspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Weight loss | |||
! rowspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Abdominal pain | |||
! rowspan="2" |Arthralgia | ! rowspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Arthralgia | ||
|- | |- | ||
! align="center" style="background:# | ! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Watery | ||
! align="center" style="background:# | ! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Fatty | ||
!WBC | ! align="center" style="background:#7d7d7d; color: #FFFFFF;" |WBC | ||
!Hgb | ! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Hgb | ||
!Plt | ! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Plt | ||
!Other lab findings | ! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Other lab findings | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" | | ! align="center" style="background:#DCDCDC;" |Whipple's disease | ||
| align="center" style="background:#F5F5F5;" | 50th | |||
| align="center" style="background:# | |||
| align="center" | +/- | | align="center" | +/- | ||
| align="center" | + | | align="center" | + | ||
Line 75: | Line 74: | ||
* [[small intestine]] [[biopsy]] for [[Tropheryma whipplei|Tropheryma whipplei]] testing | * [[small intestine]] [[biopsy]] for [[Tropheryma whipplei|Tropheryma whipplei]] testing | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | |||
| align="center" style="background:#F5F5F5;" | Childhood | |||
| align="center" style="background:# | |||
Adult | Adult | ||
Line 115: | Line 113: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Grain allergy | ! align="center" style="background:#DCDCDC;" |Grain allergy | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" |Childhood | ||
| + | | + | ||
| - | | - | ||
Line 139: | Line 137: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Infancy and childhood | ||
| align="center" | - | | align="center" | - | ||
| align="center" | + | | align="center" | + | ||
Line 168: | Line 166: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Adult | ||
| align="center" | + | | align="center" | + | ||
| align="center" | - | | align="center" | - | ||
Line 196: | Line 194: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]] | ! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Young adults | ||
(20th) | (20th) | ||
| align="center" | + | | align="center" | + | ||
Line 227: | Line 225: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]] | ! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | After childhood | ||
| align="center" | + | | align="center" | + | ||
| align="center" | - | | align="center" | - | ||
Line 254: | Line 252: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Any age | ||
| align="center" | + | | align="center" | + | ||
| align="center" | - | | align="center" | - | ||
Line 285: | Line 283: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Between 30 and 50 | ||
| align="center" | + | | align="center" | + | ||
| align="center" | - | | align="center" | - | ||
Line 311: | Line 309: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Between 30 and 50 | ||
| + | | + | ||
| - | | - | ||
Line 344: | Line 342: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]]) | ! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]]) | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Between the ages of 20 and 50 | ||
| align="center" | + | | align="center" | + | ||
| align="center" | - | | align="center" | - | ||
Line 367: | Line 365: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Any age | ||
| align="center" | - | | align="center" | - | ||
| align="center" | + | | align="center" | + | ||
Line 396: | Line 394: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | ! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Infancy | ||
| align="center" | + | | align="center" | + | ||
| align="center" | - | | align="center" | - | ||
Line 422: | Line 420: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | 30th | ||
| align="center" | + | | align="center" | + | ||
| align="center" | - | | align="center" | - | ||
Line 448: | Line 446: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption | ! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Childhood Adolescents | ||
| align="center" | + | | align="center" | + | ||
| align="center" | +/- | | align="center" | +/- | ||
Line 471: | Line 469: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | Infancy | ||
| align="center" | - | | align="center" | - | ||
| align="center" | + | | align="center" | + | ||
Line 500: | Line 498: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ||
| align="center" style="background:# | | align="center" style="background:#F5F5F5;" | 60th | ||
| align="center" | + | | align="center" | + | ||
| align="center" | - | | align="center" | - |
Revision as of 14:54, 30 October 2017
Whipple's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Whipple's disease differential diagnosis On the Web |
American Roentgen Ray Society Images of Whipple's disease differential diagnosis |
Risk calculators and risk factors for Whipple's disease differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Whipple's disease must be differentiated from other diseases that cause malabsorption, chronic diarrhea, multi system involvement, such as Celiac disease, systemic infections, and inflamatory bowel disease.
Differentiating Whipple's disease from other Diseases
Whipple's disease must be differentiated from other diseases that cause malabsorption, chronic diarrhea, joins involvement, and neurologic symptoms.
- Malabsorption with small intestine involvement (celiac disease, sarcoidosis, and lymphoma)
- Infections such as tuberculosis, endemic fungi (eg, Histoplasma spp), Rhodococcus and HIV infection
- Inflammatory bowel diseases
- Connective tissue diseases
- Neurologic disease
- Addison's disease
The following diseases have presentations similar to that of Whipple's disease.
The table below summarizes the diseases that cause malabsorption, diarrhea and abdominal pain.[1][2][3][4][5][6][7][8]
Abbreviations: WBC: White blood cells; Plt: Platelets; Hgb: Hemoglobin ; IgE: Immunoglobulin E ; IgA: Immunoglobulin A ;
Cause | Peak age of onset | History | Physical exam | Lab findings | Additional finding | Cause/Pathogenesis | Gold standard diagnosis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diarrhea | Fever | Weight loss | Abdominal pain | Arthralgia | |||||||||||
Watery | Fatty | WBC | Hgb | Plt | Other lab findings | ||||||||||
Whipple's disease | 50th | +/- | + | + | + | + | + | ↓ | ↓ | ↓ |
| ||||
Celiac disease | Childhood
Adult |
+/- | +/- | - | + | + | + | - | ↓ | - |
|
|
|
||
Grain allergy | Childhood | + | - | - | + | + | - |
|
|
| |||||
Cystic fibrosis | Infancy and childhood | - | + | + | + |
|
|
| |||||||
Lactose intolerance | Adult | + | - | - | + |
|
|||||||||
Crohns disease | Young adults
(20th) |
+ | - | + | + |
|
|
|
|
| |||||
Laxative overuse | After childhood | + | - | +/- | +/- |
|
|
- |
|
| |||||
Hyperthyroidism | Any age | + | - | + | +/- |
|
|||||||||
Irritable bowel syndrome | Between 30 and 50 | + | - | - | + |
|
- |
|
| ||||||
VIPoma | Between 30 and 50 | + | - | + | +/- |
|
|
|
| ||||||
Gastrinoma (Zollinger-Ellison syndrome) | Between the ages of 20 and 50 | + | - | + | + |
|
|
| |||||||
Lactose intolerance | Any age | - | + | + | +/- |
|
|
|
| ||||||
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | Infancy | + | - | +/- | + | Stool examination:
|
|
|
| ||||||
Eosinophilic gastroenteritis | 30th | + | - | +/- | + |
|
|
| |||||||
Primary bile acid malabsorption | Childhood Adolescents | + | +/- | + | +/- | - |
|
|
|
| |||||
Abetalipoproteinemia | Infancy | - | + | + | + |
|
|
|
|
| |||||
Microscopic colitis | 60th | + | - | + | + |
|
|
|
|
References
- ↑ Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
- ↑ Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
- ↑ BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.
- ↑ SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA (1964). "EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME". Gastroenterology. 47: 184–7. PMID 14201408.
- ↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
- ↑ Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
- ↑ RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.